Status:
COMPLETED
Dexamedatomidine vs. Dexamethasone in Rhomboidal Intercostal Plain Block and Subserratus Block in Breast Surgery
Lead Sponsor:
Armed Forces College of Medicine, Cairo, Egypt
Conditions:
Postoperative Pain, Acute
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the analgesic efficacy and safety of adding dexmedetomidine and dexamethasone to bupivacaine in rhomboidal intercostal and subserratus (RISS) block for patients un...
Detailed Description
Rhomboid intercostal block (RIB); a new interfascial plane block involves the triangle of auscultation that's bounded medially by inferior a part of the trapezius, inferiorly by the superior border of...
Eligibility Criteria
Inclusion
- Adult female patient
- Type of surgery; Modified Radical Mastectomy (MRM).
- Physical status ASA II, III.
- Age ≥ 21 and ≤ 65 Years.
- Body mass index (BMI): \> 20 kg/m2 and \< 35 kg/m2.
Exclusion
- Patient refusal.
- Patients suffering from coagulation disorders.
- Patients with histories of allergic reactions to local anesthetics or dexmedetomidine.
- Patients suffering from neuropsychiatric disorders.
- Pregnancy.
Key Trial Info
Start Date :
July 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05385523
Start Date
July 20 2022
End Date
June 15 2023
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AFCM Egypt
Cairo, Cairo Governorate, Egypt